Literature DB >> 2025985

A comparison of three desktop chemistry analyzers for the pediatric practice.

J M Hicks1, M Iosefsohn, L Greenberg.   

Abstract

Three desktop chemistry analyzers most frequently utilized in physicians' offices are compared for performance and precision: the DT60 (Kodak), Vision (Abbott), and Reflotron (Boehringer-Mannheim). The manufacturers' instructions were followed for all the reagents, calibrators and controls provided with each analyzer used. Precision, stability, dynamic range, interferences, and comparison of analyses of 50-100 patient samples with standard laboratory instruments were evaluated. Within-run precision on all three instruments was acceptable, the coefficient of variation (% CV) ranging from 0.8-5.4% and run-to-run precision CV of 1.1-7.3%. Within-run precision for glucose, blood urea, nitrogen, cholesterol and sodium for an experienced technologist, a clerk without any laboratory experience and a physician with no recent laboratory training were compared: the total CV varied between 1.1 and 6.3%. There are differences in the way bilirubin and hemoglobin interfere with the chemistries on the analyzers. Instrument size, available analyses, reagent cost and ease of operation were also assessed. The data suggest that all three analyzers performed well and would be suitable for the pediatric office setting.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025985     DOI: 10.1177/000992289103000403

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  A comparison of results of a national cholesterol and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among Americans.

Authors:  F W Fridinger; A W Jackson; J Andresen
Journal:  J Community Health       Date:  1992-08

2.  Evaluation of four hematology and a chemistry portable benchtop analyzers using non-human primate blood.

Authors:  C L Snider; E J Dick; D L McGlasson; M C Robbins; R L Sholund; Y R Bommineni; G B Hubbard
Journal:  J Med Primatol       Date:  2009-09-28       Impact factor: 0.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.